Transition report pursuant to Rule 13a-10 or 15d-10

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Mar. 31, 2018
Current assets:    
Cash $ 35,820 $ 45,833
Accounts receivable 19,561
Total current assets 55,381 45,833
Equipment, net 372,880 284,755
Security deposit 16,770
Total assets 445,031 330,588
Current liabilities:    
Accounts payable and accrued expenses 9,617 21,000
Notes payable 180,000 80,000
Convertible notes payable 1,056,000
Total current liabilities 189,617 1,157,000
Commitments and contingencies
Stockholders' equity (deficit):    
Preferred stock, $0.001 par value; 25,000,000 shares authorized; none issued or outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 39,200,090 and 21,908,810 shares issued and outstanding as of December 31, 2018 and March 31, 2018, respectively 39,200 21,909
Shares to be issued (612,000 shares) 306,000
Additional paid-in capital 2,360,598 (11,909)
Accumulated deficit (2,450,384) (836,412)
Total stockholders' equity (deficit) 255,414 (826,412)
Total liabilities and stockholders' equity (deficit) $ 445,031 $ 330,588